Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_22-1024x341.jpg)
![](https://www.copanusa.com/wp-content/uploads/2023/07/Overview_4-640x213.jpg)
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_21-640x213.jpg)
COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology
January 19, 2022
![](https://www.copanusa.com/wp-content/uploads/2022/01/phenomatrix-tag-970x536-1-640x354.jpg)
Colibri™ Automated Specimen Workup Instrument by COPAN Receives FDA 510(k) Clearance for Use with MALDI-TOF Mass Spectrometry Analyzers
January 5, 2022
![](https://www.copanusa.com/wp-content/uploads/2021/12/iStock-1206219776-1170x658-1-640x360.jpg)
COPAN Resolves U.S.I.T.C. Unfair Competition Investigation with Several Manufacturers and Distributors of Imported Flocked Swabs
December 21, 2021
![](https://www.copanusa.com/wp-content/uploads/2021/09/COPAN-UTM-foam-minitip-swabs2-970x776-1-640x512.jpg)
U.S.I.T.C Institutes Unfair Competition Investigation of Imported Flocked Swabs and Kits
September 17, 2021